nih research progress report

• Utility Menu

• Site Search
• NIH Research Performance Progress Report (RPPR)

Adapted from NIH Grants & Funding>Research Performance Progress Report

The Research Performance Progress Report (RPPR) is the progress report form used by grantees to submit progress reports to NIH. The RPPR documents grantee/recipient accomplishments and compliance with the terms of the award. There are three types of RPPRs, all of which use the NIH RPPR Instruction Guide: the Annual RPPR, the Final RPPR and the Interim RPPR.

Types of RPPRs

• Annual RPPR – The Annual RPPR is used to describe a grant’s scientific progress, identify significant changes, report on personnel, and describe plans for the subsequent budget period.
• Final RPPR – The Final RPPR is used as part of the grant closeout process to submit project outcomes.
• Interim RPPR – The interim RPPR is used when a competing renewal (Type 2 application) has been submitted. If the competing renewal is not funded, the Interim RPPR will serve as the Final RPPR for the project and no other report is required. If the renewal application is funded, the Interim RPPR will serve as the annual RPPR for the final year of the previous competitive segment.

Submitting the RPPR

All 3 types of NIH RPPRs are submitted through eRA Commons (there is no form available for download). The Annual and Interim RPPR links can be accessed through the Commons Status tab. The Interim RPPR link will appear one day after the project segment end date, but before it has moved to closeout. The Final RPPR link will become available through the closeout module once the grant is eligible for closeout.

The RPPR will not be submitted by OSP until all areas of the RPPR are in compliance with NIH guidelines and internal policies and procedures.

Annual RPPR:

• Streamlined Non-Competing Award Process (SNAP) RPPRs are due approximately 45 days before the next budget period start date.
• Non-SNAP RPPRs are due approximately 60 days before the next budget period start date. 
• Multi-year funded (MYF) RPPRs are due annually on or before the anniversary of the budget/project period start date of the award.

Interim and Final RPPR:

• 120 days from period of performance end date for the competitive segment.

Information Needed

As each award may have specific requirements depending on the NIH award mechanism, please consult the NIH RPPR Instruction Guide to determine the exact items needed for a specific project’s RPPR. At a high level, the following is needed for nearly every RPPR:

• Date due to sponsor
• An eRA Commons username and delegate access to the project director/principal investigator’s (PD/PI’s) project in eRA Commons.
• Accomplishments - NIH requires up to two pages of accomplishments exclusive of graphs and charts.
• Participants - Names and effort of all personnel that have worked at least one person-month on the project during the reporting period, regardless of the source of compensation. The PD/PI’s effort must be listed regardless if it was less than 1.0 calendar month. As a reminder, all PD/PIs on NIH awards are required to have measurable effort.
• eRA Commons usernames of all scientific staff reported on the RPPR (grad student, postdoc, PI).
• Changes in Other Support – If there have been changes in the active Other Support of Senior/Key personnel since the last reporting period, an updated Other Support page is required. Examples include if a previously active grant has terminated and/or if a previously pending grant is now active. Any changes from the previous reporting period must be annotated so it is clear what has changed from the previous submission (please note this is not needed for a Final RPPR).
• Changes in Level of Effort – It must be reported if there will be, in the next budget period, either a reduction of 25% or more in the level of effort from what was approved by the agency for the PD/PI(s) or other Senior/Key personnel designated in the Notice of Award, or a reduction in level of effort below the minimum amount of effort required by the Notice of Award.
• Unobligated Balance/Carryover greater than 25% - It must be reported if there will be an anticipated estimated unobligated balance (including prior year carryover) greater than 25% of the current year’s total approved budget.
• Publications and Inventions - Publications (compliant with NIH Public Access policy), conference papers, presentations, website(s) or other Internet site(s), reportable technologies or techniques or inventions, patent applications, and/or licenses should be listed on the RPPR.
• Training and Professional Development - Any opportunities for training and professional development on the project should be described.
• New Senior/Key Personnel - If you have new Senior/Key personnel to report, a biosketch for the new Senior/Key personnel is required.
• Changes in any human, animal, biohazard, select agent research, or foreign components, as applicable.

Roles and responsibilities:

• The department holds the primary responsibility for entering information into the RPPR forms in eRA Commons, as well as completing a corresponding Continuation request in GMAS.
• The department will route the RPPR in eRA Commons to the appropriate Awards Management contact at OSP when it is ready for submission
• The OSP Awards Awards Management team will review RPPR/Continuation requests once all required signatures are obtained on the GMAS request
• The OSP Awards Management team will submit the RPPR to the NIH in eRA Commons as the Signing/Business Official on behalf of the contact PD/PI, and mark the Continuation request as submitted in GMAS. Please note that only the project PD/PI or their PD/PI delegate can initiate RPPRs in eRA Commons. For multi-PD/PI grants only, the Contact PI or the Contact PD/PI's delegate can initiate the RPPR.
• Cash Management
• Effort Reporting & Salary Certification
• Federal Demonstration Partnership (FDP)
• Financial Management of Incoming Billing Agreements
• Managing Expenses
• Managing a Subagreement
• Prior Approval & Other Requests

The RePORT Expenditures and Results (RePORTER) module allows users to search a repository of NIH-funded research projects and access publications and patents resulting from NIH funding. Enter just about anything in the RePORTER Quick Search box above (text, PI names, project numbers, fiscal year, agency) or launch the Advanced Search to precisely configure searches using separate search fields.

RePORTER Home Advanced Search

Enter abstracts or other scientific text and Matchmaker will return lists of similar projects from RePORTER or program officials associated with those projects. These matches are based on the terms and concepts used in the submitted text. Matchmaker summarizes the projects by the program official, institute or center, review panel, and activity code.

Find a Match

Awards by Location

NIH Awards by Location - Explore year-by-year NIH funding by institution, state, congressional district, and more!

Categorical Spending

Categorical Spending displays the annual support level for various research, condition, and disease categories based on grants, contracts, and other funding mechanisms used across the National Institutes of Health (NIH), as well as disease burden data. The NIH does not expressly budget by category. The annual estimates reflect amounts that change as a result of science, actual research projects funded, and the NIH budget.

See Details

NIH Data Book

The NIH Data Book (NDB) provides basic summary statistics on extramural grants and contract awards, grant applications, the organizations that NIH supports, the trainees and fellows supported through NIH programs, and the national biomedical workforce.

Launch Data Book

Research Portfolio Online Reporting Tools (RePORT)

In addition to carrying out its scientific mission, the NIH exemplifies and promotes the highest level of public accountability. To that end, the Research Portfolio Online Reporting Tools provides access to reports, data, and analyses of NIH research activities, including information on NIH expenditures and the results of NIH supported research.

NIH COVID-19 Research Explore NIH’s comprehensive summary of ongoing COVID-19 research, including funding, clinical trials, and more. Preview a modernized RePORTER , which offers faster searches and mobile-friendly interface. Subscribe to the NIH RePORT ListServ to stay up to date on changes to these sites.

RePORT Statistics

Projects by institute/center, projects by state.

Trends in Major Fields of Study of NIH-Supported Ph.D. Recipients

Research News

News highlights.

• May 27 (Monday), 2024: NIH Closed for the Federal Holiday - Apr 2024
• Exploring the Difference Between Exempt Human Subjects Research and Expedited IRB Review - Apr 2024
• New FAQs for Early Stage Investigators - Apr 2024
• It’s Springtime! Take a Walk With the NIH Through the NIH Grants Process - Apr 2024
• Increases for National Research Service Award Stipends and Childcare Subsidies - Apr 2024

NIH… Turning Discovery Into Health ®

Division of Sponsored Programs

Nih research performance progress report (rppr), annual-rppr  --- click here  for annual-rppr instructions.  .

Interim-RPPR ---   must be   submitted via the NIH eRA Commons (click the Interim-RPPR link in the grant's Status tab) no later than 120 calendar days from the Period of Performance End Date.)

Competing Renewal ("Renewal") funded?   Interim-RPPR "turns into" an Annual-RPPR .

Competing Renewal ("Renewal") NOT funded?   Interim-RPPR "turns into" a Final-RPPR .

Final-RPPR ---   - If no Renewal application is submitted, a Final-RPPR must be submitted via the NIH eRA Commons (start by clicking the CLOSEOUT link in the grant's STATUS tab) no later than 120 days after the Period of Performance End Date.  The "Final Report" (previous format) is now called the "Final-RPPR (new format)."   EFFORT:  In the Final-RPPR (D. Participants) effort must be shown for the LAST YEAR only (prior to any no-cost extension years), and not for the entire project.  (However, the rest of the Final-RPPR deals with the ENTIRE project, not just the final year.)

  ----------------------------------------------------------------------------------------------------------- NIH RPPRs - Types - Submission - (Main NIH RPPR page)

-------------------------------------------------------------------------------- DETAILS OF THE NEW RPPR TERMINOLOGY & NIH/DSP PROCEDURES

Type 2 = Competitive Renewal (“Renewal”) or a resubmission of a Competitive Renewal (“Resubmission”)

DSP = University of Iowa Division of Sponsored Programs (Contact DSP with NIH questions:   [email protected] )

PI = Principal Investigator 

*Unfortunately, NIH publications will often refer to the Annual-RPPR (“Annual Progress Report”) as the Interim-RPPR, to be consistent with other federal agencies’ terminology for their “annual” (once per year) progress report.  Still confused?  Send a question to [email protected] (which goes to the UI Sponsored Programs Office).

The new  Final-RPPR eRA Commons module (which replaces “final reports”) will be very similar to the current Annual-RPPR format.  Notable differences are that the new  Final-RPPR will not have the following sections , which ARE found in the Annual-RPPR:

D. Participants F. Changes H. Budget I. Outcomes   The new Project Outcomes (Section I) will be made publicly available, allowing recipients the opportunity to provide the general public with a concise summary of the public significance of the research.

Competitive Renewal (“Renewal”) (Type 2) applications still require the same Progress Report as part of the Research Strategy section:

------------------------------------------------------------- Progress Report for Renewal and Revision [of a Renewal] Applications:

Note that the Progress Report falls within the Research Strategy and is therefore included in the page limits for the Research Strategy.

For renewal/revision applications, provide a Progress Report. Provide the beginning and ending dates for the period covered since the last competitive review. In the Progress Report, you should:

• Summarize the specific aims of the previous project period and the importance of the findings, and emphasize the progress made toward their achievement.

• Explain any significant changes to the specific aims and any new directions, including changes resulting from significant budget reductions.

• Discuss previous participant enrollment (e.g., recruitment, retention, inclusion of women, minorities, children, etc.) for any studies meeting the NIH definition for clinical research, particularly if relevant to studies proposed in the renewal or revision application. You should not submit a PHS Inclusion Enrollment Report unless the enrollment is part of new or ongoing studies in the renewal or revision application.

Do not include a list of publications, patents, or other printed materials in the Progress Report. That information will be included in the "Progress Report Publication List" attachment.

http://grants.nih.gov/grants/how-to-apply-application-guide/forms-d/general/g.400-phs-398-research-plan-form.htm#Research

-------------------------------------------------------------

NEW RPPR POLICIES AND PROCEDURES     NIH Implementation of Final Research Performance Progress Reports (Final RPPR)     NOT-OD-17-022     NIH Implementation of the Interim-RPPR while a Renewal Application is Under Consideration     NOT-OD-17-037

Research Performance Progress Report (RPPR) (Main NIH RPPR page)

----------------------------------------------------------------------- ANNUAL-RPPR

The purpose of the Annual-RPPR (or "annual progress report" or "non-competing renewal") is to provide NIH with information on the progress of your project over the past year, and what you hope to accomplish in the next year, so that the next year of funding can be released by NIH.  

For the UI Principal Investigator (PI), completing the Annual-RPPR and submitting it to NIH requires a two-step process, both of which must be completed 5 business days prior to the NIH Annual-RPPR due date:

• Completing the Annual-RPPR itself on the NIH eRA Commons , routing it to Jeanne Towell, Archana Shah, Deidra Slough or Bethan Campbell Tvedt on the NIH eRA Commons, and  
• Completing the UI Proposal Routing Form (as required for all requests for external funding)

Review of the Annual-RPPR by UI Sponsored Programs does not begin until these two steps are completed.

For an NIH overview of the Annual-RPPR:   Research Performance Progress Report (RPPR) .

Annual-RPPR - Preparation Highlights

The Annual-RPPR reports to NIH information on the project’s progress and results, the significance of findings, and any significant changes in personnel and/or direction. 

Annual-RPPR items that often cause problems, or contain NEW requirements:

•  All NIH-Funded Clinical Trials.  New HHS rule and NIH policy, effective January 18, 2017, affect all NIH-funded clinical trials. Read the  summary . . Certifying compliance with FDAAA ( Food and Drug Administration Amendments Act of 2007) in [applications and] progress reports. . NIH Implementation of FDAAA  (new clinical trial regulations) in competing applications and non-competing (Annual RPPR) applications. . FAQs - Further Resources for NIH Grantees F DAAA . The certification of compliance with FDAAA required by the NIH is different than that required by the Food and Drug Administration (FDA).  To learn more about the FDA certification of compliance, please access the ClinicalTrials.gov Web site on  Certification of Compliance to FDA . . For NON-COMPETING CONTINTUATION PROGRESS REPORTS (ANNUAL RPPRs) for a project that includes applicable clinical trial/s:  . If a  new applicable clinical trial is proposed -OR- if the progress report includes an applicable clinical trial that is on-going but not yet required to register under FDAAA  (e.g. less than 21 days have passed since enrollment of the first subject), the Human Subjects section of the progress repo r t (Annual RPPR) must include a clear statement, under a heading entitled “ClinicalTrials.gov”, that the project includes an applicable clinical trial which will require registration in ClinicalTrials.gov.  . Remember, FDAAA requires that applicable clinical trials be registered in ClinicalTrials.gov no later than 21 days after the first subject is enrolled. . If the progress report includes  an applicable clinical trial that is registered in ClinicalTrials.gov , then the Human Subjects section of the progress report must include: .      Under a heading entitled “ClinicalTrials.gov”      ClinicalTrials.gov registry number (which is “NCT” followed by an 8-digit number, e.g. NCT00000418),      Brief Title (protocol title intended for the lay public), and      Identity (name, organization) of the responsible party and their contact information (e-mail address -             required for internal administrative use only). . The on-line Annual RPPR form on the NIH eRA Commons also has a section for this information:         G.4.c ClinicalTrials.gov        Does this project include one or more applicable clinical trials that must be registered in                 ClinicalTrials.gov under FDAAA?  YES/NO        If yes, provide the ClinicalTrials.gov identifier, NCT number (e.g., NCT00654321) for those trials.        [Data entry box] . The signature on the non-competing continuation progress report (Annual RPPR) of the Authorized Organizational Representative (Signing Official) assures compliance with FDAAA.   
• "Rigor & Reproducibility "  (you may need to right click and open in a new tab.) guidelines require a discussion of these concepts, as they apply to your research, specifically in B2 and B6 of the "B. Accomplishment" section of your RPPR.  Simple Solution: Include a short paragraph with the heading "Rigor & Transparency" in both B2 and B6.   FAQs .   Training VIDEO (30 min) .
• C.2. (Websites...), C.3. (Technologies...) and C.5. (Other products...) sections of the RPPR *scrollable menu lists 14 item categories After entering a description for one or more items in a text box, you then select appropriate categories using the scrollable menu.  You are not limited to a single menu category per product. The list of item types includes: Audio/video; Data/Databases; Research material; educational aids/curricula; evaluation instruments/equipment; models; physical collections; protocols; software; survey instruments; interventions (clinical/educational); New business creation; Other. . See also " Guide to Categorizing Products in RPPR's Section C " for more details.  (you may need to right click and open in a new tab.) .
• Effort: The metric for expressing the effort (amount of time) devoted to a specific project. The effort is based on the type of appointment of the individual with the organization; e.g., calendar year, academic year, and/or summer term; and the organization's definition of such. For instance, some institutions define the academic year as a 9-month appointment while others define it as a 10-month appointment.
• Include (1) the PD/PI regardless of effort devoted to the project and (2) each person who has worked at least one person month per year on the project during the reporting period, regardless of the source of compensation. Round to the nearest one-tenth (i.e., one decimal place) of a person month that the individual worked on the project. https://grants.nih.gov/grants/rppr/index.htm  (you may need to right click and open in a new tab.) . Recall that there are two type of appointments, Calendar Year Appointment and Academic Year Appointment, each with its own way of recording effort. . Calendar Year (12-month) Appointment : Effort is shown in whole "Cal" months.   For example: 2 Cal  [0 Aca; 0 Sum = not used] . Academic Year (9-month) Appointment : Effort is shown in whole "Aca" months PLUS "Sum" months.   For example:  [0 Cal = not used]  3 Aca 1 Sum. Note that an Academic Appointment can be paid over 12 months to "even out the paychecks," but that does not make it a Calendar Year Appointment.
• NIH Commons ID:  Do you have undergraduate students , graduate students , or postdoctoral participants working on the grant?  Then you MUST include an NIH Commons ID for each of them in "D. Participants/List of Participants."  To obtain an NIH Commons ID, contact UI Sponsored Programs at  [email protected]​      . AN ERROR WILL BE SEEN FOR THE RPPR unless undergraduate students, graduate students and postdocs complete their eRA Commons Profile after obtaining their username and password.  They  are required to answer certain demographic questions related to date of birth, gender, race, ethnicity, disabilities, US citizenship status and country of citizenship; and where applicable, they will need to indicate their highest educational degree and the institution where it was earned, in order to complete the data collection.   NOT-OD-13-097   .
• Institutional Development Plan (IDP)   DISCUSSION  (not the IDP itself) is required  at "B. Accomplishments/B.4" if you have graduate students or postdoctoral participants on the grant.   THIS IS NOT JUST FOR TRAINING GRANTS.  IT APPLIES TO ALL GRANTS .  For more information on how to "discuss" the IDP, see the UI Graduate College's page on the Individual Development Plan .   

Helpful Links for the Annual-RPPR

• NIH eRA Commons Login   (Need an NIH Commons ID/password to log in?  Contact UI Sponsored Programs at  [email protected] )  
• Research Performance Progress Report (RPPR) - Main NIH information page for the RPPR  
• Research Performance Progress Report (RPPR) **Instruction Guide**  
• Individual Development Plan (IDP) - UI Graduate College  
• **NEW REQUIREMENT**  "Rigor & Reproducibility " (also called "Rigor & Transparency") guidelines and definitions  
• **NEW**   Guide to Categorizing Products in RPPR's Section C

• U.S. Department of Health & Human Services

• Virtual Tour
• Staff Directory
• En Español

You are here

News releases.

Media Advisory

Thursday, April 25, 2024

NIH RECOVER makes long COVID data easier to access

Deidentified data from thousands of adults with long COVID are now available to researchers.

Secure data from more than 14,000 adults who participate in National Institutes of Health observational research on long COVID are now available to authorized researchers through BioData Catalyst (BDC). BDC is a cloud-based ecosystem developed by the National Heart, Lung, and Blood Institute (NHLBI), part of NIH, to accelerate research on heart, lung, blood, and sleep disorders. The research on long COVID — broadly defined as signs, symptoms, or conditions that persist or develop for at least four weeks after an infection from the virus that causes COVID-19 — is provided through the NIH Researching COVID to Enhance Recovery (NIH RECOVER) Initiative.

By giving researchers access to secure data, analysis tools, and resources, the BDC ecosystem aims to spur scientific innovation, collaboration, and discovery, while providing a platform for sharing data and validating results. The addition of RECOVER data to BDC can help investigators identify and explore long COVID connections that may benefit from or inform future studies.

Authorized researchers can now request access to a subset of data from adults in the observational RECOVER cohort. These data include information from more than 92,000 study visits collected between Oct. 29, 2021-Sept. 15, 2023 at 79 locations throughout the United States. New RECOVER data, including data from other studies, will be added to BDC at regular intervals.

As investigators seek to better understand, diagnose, and treat long COVID, many critical questions remain. By making RECOVER data more accessible by adding it to a central ecosystem, experts aim to find answers sooner.

David C. Goff, M.D., Ph.D. , a senior scientific program director for the RECOVER Observational Consortium Steering Committee and director of the Division of Cardiovascular Sciences at NHLBI, is available to discuss BDC and new directions in long COVID research.

About RECOVER: The National Institutes of Health Researching COVID to Enhance Recovery (NIH RECOVER) Initiative is a $1.15 billion effort, which is supported in part through the American Rescue Plan Act of 2021. It seeks to identify how people recuperate from COVID-19 and who is at risk for developing post-acute sequelae of SARS-CoV-2 (PASC). Researchers are also working with patients, clinicians, and communities across the United States to identify strategies to prevent and treat the long-term effects of COVID, including long COVID. For more information, please visit recovercovid.org .

About the National Heart, Lung, and Blood Institute (NHLBI): NHLBI is the global leader in conducting and supporting research in heart, lung, and blood diseases and sleep disorders that advances scientific knowledge, improves public health, and saves lives. For more information, visit https://www.nhlbi.nih.gov .

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov .

NIH…Turning Discovery Into Health ®

Connect with Us

• More Social Media from NIH

• NIH Grants & Funding
• Blog Policies

NIH Extramural Nexus

Increases for National Research Service Award Stipends and Childcare Subsidies

We are committed to sustaining the vitality of the future biomedical research workforce, including providing appropriate support and addressing the many challenges faced by postdoctoral scholars in biomedicine. As part of this commitment, we are pleased to announce stipend and childcare subsidy increases for the over 17,000 early career scholars supported on NIH Kirschstein National Research Service Awards (NRSAs) ( NOT-OD-24-104 ). Stipends will be raised by 4% for predoctoral trainees and by 8% for postdoctoral scholars in fiscal year (FY) 2024 compared to last year), the most substantial year over year increase since FY 2017. Additionally, the childcare subsidy will be increased by an additional $500 (from $2500 to $3000) in FY24.

Appropriate support for early career researchers is something we take seriously. The Advisory Committee to the NIH director (ACD) , following thoughtful deliberations on re-envisioning the NIH-supported postdoctoral experience, reiterated that financial concerns were a topmost challenge for postdoctoral scholars. Echoing sentiments made in their final report from last December (see recommendation 1.1), lack of appropriate support dissuades some individuals to pursue a research career because of the negative effects on financial security.

The new stipend levels begin at $61,008 and are upwardly adjusted based on years of experience. In addition to higher stipend levels, there is also a modest $200 increase in training-related expenses and institutional allowances . Tuition and Fees for all educational levels remain unchanged from last year.

This is a significant step given a relatively flat NIH budget (see this recent blog about the interplay between budgets and success rates). The approach allows for an immediate stipend increase without drastic cuts to the number of available awards. As appropriations and budget realities allow, our goal is to reach the ACD recommended stipend levels (around $70,000 per year for postdoctoral scholars) in the coming years.

As we move toward that goal, institutions should note that:

• As noted in the NIH Grants Policy Statement (e.g., 11.2.10.1), “Kirschstein-NRSA fellows receive  stipends  to defray living expenses.  Stipends  may be supplemented by an institution from non-Federal funds provided this supplementation is without any additional obligation for the fellow.”
• Recipient institutions are reminded that they are not prohibited from hiring NRSA trainees and fellows as employees or provide them with benefits consistent with what the institution provides others at similar career stages.

Raising NRSA stipends and childcare subsidies are only two ways we are committed to fostering a strong and robust future workforce. We will continue to assess our policies and procedures. We anticipate releasing a request for information (RFI) in the near future to seek input on specific recommendations from the ACD.

Read the NIH press release for more.

RELATED NEWS

Is this increase only for NRSA fellows or all fellows supported by NIH RO1 grants?

Another unfunded mandate by NIH. Great idea in theory but without also increasing funding this is another hit to an already stressed research climate.

As far as I can tell, the child care subsidy (which is a great idea) is not available to trainees supported by other mechanisms (e.g., R01s). Is that correct? If so, why?

Is this increase only for new awards, or will the new rates be applied to current awards? If applied to current awards, will it be done at the start of a new budget year, or will current awards be revised with the increase?

NIH keeps ignoring the biggest problem facing NRSA F32/T32 recipients: their stipends cannot be used by host institutions as conditions for employment, preventing institutions from offering equal benefits to postdocs who receive these “prestigious” awards. Just change the rule, and if you refuse, then it would honestly be better to get rid of the funding mechanisms and create something new that didn’t have this one ridiculous clause (11.2.9.2) that causes so much pain and frustration. Until this happens, then all other announcements on these awards are mere hand-waving and shadow play.

I am an NIH postdoctoral scholar. However, I couldn’t see any increase for my April 2024 stipend. Will we see this stipend increase next month for May 2024 stipend payment. Thank you

Meanwhile, NIAID is cutting all R01 and many other budgets by 10% and doesn’t allow a PI to budget for yearly salary increases, as far as I am aware. While many PI’s support the pay increases, how they are funded from fixed flat budgets is becoming a major challenge to research budgets. Ultimately, higher pay will also mean fewer positions and a big change in how we view postdoctoral research positions.

Before submitting your comment, please review our blog comment policies.

Your email address will not be published. Required fields are marked *

April 30, 2024

Consequences for Late or Missing Progress Reports

Sponsors are continuing to increase scrutiny and enforcement of progress and technical reporting requirements.

Importance of Timely Progress Reports

Recipient failure to submit progress reports (including annual and final reports) to sponsors results in a variety of potential consequences and corrective actions from both the sponsor and the University.

Sponsors may decide to suspend or terminate current awards and/or withhold current and future support not only to the awarded PI but to the entire University.

GIM 39 highlights potential consequences:

• Sponsor actions (delay awards, withhold awards, require different payment method, suspend awards)
• OSP will not review or submit proposals
• OSP and GCA restrictions

We strongly urge all UW Principal Investigators:

• To follow sponsor deadlines and guidelines for progress & technical report submission.
• To make it a priority to submit overdue progress reports .
• Who plan to retire or transfer to another institution to submit all progress/technical reports (including any final reports) before leaving the UW.

We also encourage department staff to remind their PIs to submit their reports in a timely manner and make sure that retiring or transferring PIs have submitted all their required reports before they leave.

• Use IPF# 9087701 to search for UW PIs
• NIH NOT-OD24-055 Enforcement of Unilateral Closeout Reporting
• NIH GPS 8.5.2 Remedies for Noncompliance or Enforcement Actions
• UW GIM 39 – Consequences

University of Washington Office of Research

Or support offices.

• Human Subjects Division (HSD)
• Office of Animal Welfare (OAW)
• Office of Research (OR)
• Office of Research Information Services (ORIS)
• Office of Sponsored Programs (OSP)

OR Research Units

• Applied Physics Laboratory (APL-UW)
• WA National Primate Research Center (WaNPRC)

Research Partner Offices

• Corporate and Foundation Relations (CFR)
• Enivronmental Health and Safety (EH&S)
• Grant and Contract Accounting (GCA)
• Institute of Translational Health Sciences (ITHS)
• Management Accounting and Analysis (MAA)
• Post Award Fiscal Compliance (PAFC)

Collaboration

• Centers and Institutes
• Collaborative Proposal Development Resources
• Research Fact Sheet
• Research Annual Report
• Stats and Rankings
• Honors and Awards
• Office of Research

© 2024 University of Washington | Seattle, WA